Business Description
Vaxart Inc
NAICS : 325414
SIC : 2836
ISIN : US92243A2006
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.98 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -0.28 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -6.46 | |||||
Beneish M-Score | 72.72 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.5 | |||||
3-Year EBITDA Growth Rate | -17.1 | |||||
3-Year EPS without NRI Growth Rate | -15.8 | |||||
3-Year FCF Growth Rate | -20.8 | |||||
3-Year Book Growth Rate | -30.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.5 | |||||
9-Day RSI | 16.86 | |||||
14-Day RSI | 23.49 | |||||
6-1 Month Momentum % | 90.86 | |||||
12-1 Month Momentum % | 87.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.32 | |||||
Quick Ratio | 3.32 | |||||
Cash Ratio | 2.89 | |||||
Days Sales Outstanding | 30.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | -14.93 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -915.5 | |||||
Net Margin % | -905.81 | |||||
FCF Margin % | -801.96 | |||||
ROE % | -99.42 | |||||
ROA % | -68.29 | |||||
ROIC % | -138.94 | |||||
ROC (Joel Greenblatt) % | -202.41 | |||||
ROCE % | -75.99 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.92 | |||||
PB Ratio | 1.88 | |||||
Price-to-Tangible-Book | 2.2 | |||||
EV-to-EBIT | -1.28 | |||||
EV-to-EBITDA | -1.44 | |||||
EV-to-Revenue | 11.4 | |||||
EV-to-Forward-Revenue | 3238.85 | |||||
EV-to-FCF | -1.43 | |||||
Price-to-Median-PS-Value | 3.31 | |||||
Price-to-Net-Current-Asset-Value | 9.44 | |||||
Price-to-Net-Cash | 16.53 | |||||
Earnings Yield (Greenblatt) % | -78.13 | |||||
FCF Yield % | -58.61 | |||||
Forward Rate of Return (Yacktman) % | -2073.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vaxart Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.376 | ||
EPS (TTM) (€) | -0.538 | ||
Beta | -0.46 | ||
Volatility % | 115.89 | ||
14-Day RSI | 23.49 | ||
14-Day ATR (€) | 0.048905 | ||
20-Day SMA (€) | 0.932275 | ||
12-1 Month Momentum % | 87.44 | ||
52-Week Range (€) | 0.5016 - 1.36 | ||
Shares Outstanding (Mil) | 173.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vaxart Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vaxart Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Vaxart Inc Frequently Asked Questions
What is Vaxart Inc(STU:NB11)'s stock price today?
When is next earnings date of Vaxart Inc(STU:NB11)?
Does Vaxart Inc(STU:NB11) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |